Abstract
<i>Introduction</i>: male hypogonadism is defined by the European Association of Urology 2022 as being associated with reduced testicular function, reduced androgen production, and/or impaired sperm production. Male hypogonadism has many causes and accompanying diseases such as diabetes, varicocele, etc. Male hypogonadism hadsymptoms of varicocele and had two treatment options: testosterone replacement therapy or surgical treatment of varicocele. Each method has different advantages and disadvantages, so we research to evaluate each treatment method’s results. <i>Objectives: </i>Evaluate the results of male hypogonadism treatment of testosterone replacement therapy or varicocele surgery. <i>Material and methods: </i>conducted a cross-sectional descriptive study in 111 men with symptoms of hypogonadism from January 2022 to the end of 2023. <i>Result: </i>The average age was 65.2 ± 2.4 years. The Androgen Deficiency in Aging Males (ADAM) questionnaire has the highest rate of 90.99% showing symptoms of decreased erection strength. Hypogonadism is associated with body mass index and diabetes. After treatment, the hypogonadism group with grade III varicocele had the lowest response to treatment. After treatment, total testosterone in blood levels in all treatments increased (p<0.001). <i>Conclusion: </i>Testosterone replacement therapy for hypogonadism without varicocele is the gold standard, and microsurgical treatment for hypogonadism with varicocele is the most effective.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call